JAMES J. NORDLUND, M.D.; VINCENT T. DEVITA, M.D.; PAUL P. CABBONE, M.D.
This content is PDF only. Please click on the PDF icon to access.
A pregnant woman was treated with vinblastine for Hodgkin's disease. Despite the mother's severe bone marrow suppression from vinblastine at delivery, the fetus demonstrated no significant toxicity. Pharmacologic doses of steroids were unable to protect against an anaphylactic reaction.
NORDLUND JJ, DEVITA VT, CABBONE PP. Severe Vinblastine-Induced Leukopenia During Late Pregnancy with Delivery of a Normal Infant. Ann Intern Med. 1968;69:581–582. doi: https://doi.org/10.7326/0003-4819-69-3-581
Download citation file:
Published: Ann Intern Med. 1968;69(3):581-582.
Emergency Medicine, Hematology/Oncology, Leukemia/Lymphoma.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use